The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.
Kite, part of Gilead Sciences, and Shoreline Biosciences, a San Diego, California-based company developing allogeneic cellular immunotherapies for cancer and other diseases, have entered into a strategic partnership, worth up to $2.3-billion,...
Bristol-Myers Squibb (BMS) and Eisai have entered into an exclusive global strategic collaboration agreement for the co-development and co-commercialization of Eisai’s MORAb-202, an antibody drug conjugate (ADC), in a $3.1-billion deal ($645...
The latest on COVID-19 vaccines/drugs and manufacturing from J&J, AstraZeneca, Pfizer, Novavax, Regeneron, CureVac, Daiichi Sankyo, and the US government.
Manufacturing and supply of COVID-19 vaccines and drugs
Update on Mfg Review of...
The US government has purchased an additional 200 million doses of Moderna’s COVID-19 vaccine, and the European Medicines Agency (EMA) has approved a new manufacturing site for the vaccine. Moderna has also formed pacts with the United Arab...
Leaders from the G-7 countries (Canada, France, Germany, Italy, Japan, the UK, and the US) announced at the G-7 Summit, held earlier this month (June 2021) in Cornwall, UK, that they have committed to provide at least 870 million additional doses...
Civica Rx, a non-profit pharmaceutical company providing generic drugs, including drugs in shortage, has announced CivicaScript as the name of its new retail generics operating unit. Additionally, Anthem, a health insurance company, has become a...
GlaxoSmithKline (GSK) and iTeos Therapeutics, a Cambridge, Massachusetts-based bio/pharmaceutical company, have agreed to co-develop and co-commercialize iTeos’ immuno-oncology drug candidate, EOS-448, in a deal worth up to $2.075 billion ($625...
Elanco Animal Health, the former animal-health business of Eli Lilly and Company and now a stand-alone company, has agreed to sell two manufacturing sites in Shawnee, Kansas, and Speke, UK to Tris Pharmaceuticals, a Norwalk, Connecticut-based CDMO....
Bayer is investing EUR 250 million ($303 million) to build a new pharmaceutical plant and concurrently modernize its existing production plant in Turku, Finland.
The new production plant will be built on an existing building in Artukais, Turuk,...
The Biden Administration has announced a series of actions and recommendations to improve supply-chain resilience in several industries, including pharmaceuticals.
In February (February 2021), President Joe Biden issued an executive order that...
The European Union (EU) has submitted its proposal seeking the commitment of World Trade Organization (WTO) members for a multilateral trade action plan to expand the production of COVID-19 vaccines and treatments and ensure universal and fair...
Merck & Co. has entered into a procurement agreement, worth up to $1.2 billion, with the US government for molnupiravir, its investigational oral antiviral agent for treating mild-to-moderate COVID-19.
Molnupiravir is currently being evaluated...
The latest on COVID-19 vaccines/drugs, manufacturing, and testing from Pfizer, Moderna, Roche, Thermo Fisher, Inovio, Regeneron, the US government, and others.
Manufacturing and supply of COVID-19 vaccines and drugs
Pfizer/BioNTech, US in COVID...
A roundup of news from Canada (Fusion Pharmaceuticals), France (Sanofi), Japan (Otsuka), and the US (bluebird bio).
Canada
Fusion Pharmaceuticals Partners for New Radiopharma Mfg FacilityFusion Pharmaceuticals, a Hamilton, Ontario, Canada-based...
The US Food and Drug Administration (FDA) has granted accelerated approval for Biogen’s and Eisai’s Aduhelm (aducanumab) for treating Alzheimer’s disease. It is the first new treatment approved by the FDA for Alzheimer’s since 2003 and is the first...
